These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38917808)

  • 1. Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases.
    Kumbhari A; Cheng TNH; Ananthakrishnan AN; Kochar B; Burke KE; Shannon K; Lau H; Xavier RJ; Smillie CS
    Cell Host Microbe; 2024 Jul; 32(7):1147-1162.e12. PubMed ID: 38917808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
    Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
    Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease.
    Wiredu Ocansey DK; Hang S; Yuan X; Qian H; Zhou M; Valerie Olovo C; Zhang X; Mao F
    Gut Microbes; 2023; 15(1):2176118. PubMed ID: 36794838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.
    Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC
    Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
    Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
    Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
    mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
    Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients.
    Hall AB; Yassour M; Sauk J; Garner A; Jiang X; Arthur T; Lagoudas GK; Vatanen T; Fornelos N; Wilson R; Bertha M; Cohen M; Garber J; Khalili H; Gevers D; Ananthakrishnan AN; Kugathasan S; Lander ES; Blainey P; Vlamakis H; Xavier RJ; Huttenhower C
    Genome Med; 2017 Nov; 9(1):103. PubMed ID: 29183332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice.
    Torres J; Hu J; Seki A; Eisele C; Nair N; Huang R; Tarassishin L; Jharap B; Cote-Daigneault J; Mao Q; Mogno I; Britton GJ; Uzzan M; Chen CL; Kornbluth A; George J; Legnani P; Maser E; Loudon H; Stone J; Dubinsky M; Faith JJ; Clemente JC; Mehandru S; Colombel JF; Peter I
    Gut; 2020 Jan; 69(1):42-51. PubMed ID: 31036757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiota of Inflammatory Bowel Disease Models.
    Gao Z; Chen KY; Mueller O; Zhang H; Rakhilin N; Chen J; Shen X
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():2374-2377. PubMed ID: 30440884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.
    Vich Vila A; Imhann F; Collij V; Jankipersadsing SA; Gurry T; Mujagic Z; Kurilshikov A; Bonder MJ; Jiang X; Tigchelaar EF; Dekens J; Peters V; Voskuil MD; Visschedijk MC; van Dullemen HM; Keszthelyi D; Swertz MA; Franke L; Alberts R; Festen EAM; Dijkstra G; Masclee AAM; Hofker MH; Xavier RJ; Alm EJ; Fu J; Wijmenga C; Jonkers DMAE; Zhernakova A; Weersma RK
    Sci Transl Med; 2018 Dec; 10(472):. PubMed ID: 30567928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Gut Microbe-Derived Extracellular Vesicles to Differentiate Inflammatory Bowel Disease Patients from Healthy Controls.
    Heo M; Park YS; Yoon H; Kim NE; Kim K; Shin CM; Kim N; Lee DH
    Gut Liver; 2023 Jan; 17(1):108-118. PubMed ID: 36424722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study.
    De Caro C; Spagnuolo R; Quirino A; Mazza E; Carrabetta F; Maurotti S; Cosco C; Bennardo F; Roberti R; Russo E; Giudice A; Pujia A; Doldo P; Matera G; Marascio N
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.